Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 63629-2373

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 63629-2373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292373)

This is a medication description for Chlordiazepoxide HCI and Clidinium Bromide Capsules. Each capsule contains 5mg of Chlordiazepoxide Hydrochloride, USP and 2.5mg of Clidinium Bromide, USP. The medication is for adults and should be taken 1-2 capsules three or four times a day, before meals and at bedtime. The medication should be kept out of reach of children and stored at 20° to 25°C (68° to 77°F). The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The product is available in a 100-cap bottle.*

FDA Label Image

Structure Chlordiazepoxide

FDA Label Image

Structure Clidinium

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.